Search results for "COVID-19"
Testing offers hope, no panacea for COVID-19 control
A Q&A offers expert advice on the latest information about testing for COVID-19 from Elisa I. Choi, MD, FACP, Governor for ACP's Massachusetts Chapter and a fellow of the Infectious Diseases Society of America.
https://acpinternist.org/archives/2020/06/testing-offers-hope-no-panacea-for-covid-19-control.htm
1 Jun 2020
Sepsis associated with higher cardiovascular risk after hospitalization
A retrospective cohort analysis of 2.25 million U.S. patients found that those with sepsis were at higher risk for all-cause mortality and rehospitalization for each major type of cardiovascular disease event, particularly heart failure, than those without.
https://acpinternist.org/weekly/archives/2023/02/07/4.htm
7 Feb 2023
Antibiotic stewardship improved prescribing for suspected UTI in frail older adults
Inappropriate antibiotic prescribing for suspected urinary tract infections (UTIs) was reduced in practices and facilities assigned to use a decision tool instead of usual care, particularly for patients with dementia, a randomized trial in Europe found.
https://acpinternist.org/weekly/archives/2023/02/28/5.htm
28 Feb 2023
10 tips for well-being amid COVID-19
The global pandemic has professional and personal consequences for physicians, so experts offer their advice on coping during COVID-19.
https://acpinternist.org/archives/2020/07/10-tips-for-well-being-amid-covid-19.htm
1 Jul 2020
Nirmatrelvir/ritonavir rarely leads to rebound, doesn't help average-risk patients, studies find
A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
https://acpinternist.org/weekly/archives/2022/06/21/2.htm
21 Jun 2022
Details on second mRNA COVID-19 vaccine boosters
This column reviews details on recent recalls, alerts, and approvals.
https://acpinternist.org/archives/2022/05/details-on-second-mrna-covid-19-vaccine-boosters.htm
1 May 2022
IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir
The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital profits during the pandemic.
https://acpinternist.org/weekly/archives/2022/05/17/2.htm
17 May 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://acpinternist.org/archives/2023/07/latest-updates-on-acps-priorities-initiatives.htm
1 Jul 2023
Recommendations on avoiding drug-drug interactions, data on recovery after ventilation
A panel of experts offered advice on avoiding drug-drug interactions when prescribing nirmatrelvir-ritonavir for patients with COVID-19, and two studies offered good news about postdischarge outcomes in COVID-19 patients who underwent a tracheostomy.
https://acpinternist.org/weekly/archives/2022/03/01/4.htm
1 Mar 2022
Two studies show effectiveness of mRNA boosters against omicron variant
Other recent research on COVID-19 revealed the high transmissibility of the omicron stealth variant and changes in the brain after SARS-CoV-2 infection.
https://acpinternist.org/weekly/archives/2022/03/15/5.htm
15 Mar 2022